Batallas, Daniela
Gallego, Juan José
Casanova-Ferrer, Franc
Fiorillo, Alessandra
Rivas-Diaz, Pablo
López-Gramaje, Adrià
Arenas, Yaiza M.
Aparicio, Luis
Escudero-García, Desamparados
Durbán, Lucía
Rios, María-Pilar
Benlloch, Salvador
Urios, Amparo
Hidalgo, Vanesa
Montoliu, Carmina https://orcid.org/0000-0002-4740-4788
Salvador, Alicia
Funding for this research was provided by:
Agència Valenciana de la Innovació (Consolidacio Cadena Valor)
Generalitat Valenciana (CIPROM2021/082)
Generalitat Valenciana (co-funded ERDF funds)
Generalitat Valenciana (CIAPOT /2021/20)
Instituto de Salud Carlos III (PI23/00062)
Instituto de Salud Carlos III (co-funded ERDF funds)
F. Sarabia Donation (PRV00225)
Universidad de Valencia (Ayudas para Acciones Especiales (UV-INV_AE-2633839))
Ministerio de Universidades (Margarita Salas grant (MS21-120))
Ministerio de Ciencia e Innovación (PID2020-119406GB-I00/ AEI / 10.13039/501100011033))
INCLIVA/Universidad de Valencia (Programa de Proyectos de Investigación Traslacional VLC-Bioclinic (PI-2023-001))
European Commission (Operational Program of the European Regional Development Fund (FEDER) of the Comunidad Valenciana 2014–2020)
Universitat de Valencia
Article History
Accepted: 3 February 2025
First Online: 1 April 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Study protocols were approved by the Research Ethics Committees of Hospital Clinico Universitario and Arnau de Vilanova Hospital of Valencia, Valencia, Spain (approval code: 2018/210; approval date: 2 March 2018) and were in accordance with the ethical guidelines of the Helsinki Declaration.
: Written informed consent was obtained from all individual participants included in the study.